ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Melanoma and other Skin Tumours
Latest ESMO videos
Featured medwireNews
Stage III High-Risk Melanoma Benefits With Dabrafenib–Trametinib, Pembrolizumab
Continuous BRAF–MEK inhibition Best For BRAF-Mutated Melanoma
Immune-Related Adverse Event Risks Differ By ICI Regimen in Advanced Melanoma
COMBI-AD Biomarker Analysis May Help Guide Stage III Melanoma Care
Cemiplimab Active, Well Tolerated For Locally Advanced Cutaneous SCC
E-Learning
ESMO V-Learning: BRAF Mutations Across Cancers
ESMO E-Learning: New Treatments in Melanoma
ESMO V-Learning: Inhibition of MEK to Treat Cancer, focussing on Melanoma
Factsheets on Biomarkers
PD-L1 in Cancer: ESMO Biomarker Factsheet
NRAS in Melanoma: ESMO Biomarker Factsheet
BRAF in Melanoma: ESMO Biomarker Factsheet
Meeting resources
Management and learnings from toxicity?
Presenter: Caroline Robert
Session: Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps
Resources:
Slides
Webcast
Clinical and molecular characteristics of resistance to immunotherapy
Presenter: Thomas Gajewski
Session: Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps
Resources:
Slides
Webcast
Translational research: Ready for patient selection?
Presenter: Christian Blank
Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?
Resources:
Slides
Webcast
Adjuvant and neo-adjuvant therapy
Presenter: Georgina Long
Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?
Resources:
Slides
Webcast
Controversies in the surgical management of stage III melanoma
Presenter: Merrick Ross
Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.